Citation Impact

Citing Papers

2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
Genetic polymorphism of the Nrf2 promoter region is associated with vitiligo risk in Han Chinese populations
2016
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment
2015 Standout
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
2013 Standout
Role of α-Synuclein in Inducing Innate and Adaptive Immunity in Parkinson Disease
2015
Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview
2014
Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimers Disease
2011
Ischemia and reperfusion—from mechanism to translation
2011 Standout
A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome
2015
The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer’s disease
2010
The −1082G/A polymorphism in IL-10 gene is associated with risk of Alzheimer's disease: A meta-analysis
2011
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
The role of autophagy in neurodegenerative disease
2013 Standout
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
2019 Standout
Alzheimer's disease
2011 Standout
Glycogen synthase kinase‐3β and tau genes interact in Alzheimer's disease
2008
Role of the Peroxynitrite-Poly(ADP-Ribose) Polymerase Pathway in Human Disease
2008
Rapid β-Amyloid Deposition and Cognitive Impairment After Cholinergic Denervation in APP/PS1 Mice
2013
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Microglial cell origin and phenotypes in health and disease
2011 Standout
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
2014 Standout
Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism
2016 Standout
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
2018 Standout
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Toll-Like Receptors in Alzheimer's Disease
2009
Overexpression of Low-Density Lipoprotein Receptor in the Brain Markedly Inhibits Amyloid Deposition and Increases Extracellular Aβ Clearance
2009
Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis
2008
LRRK2 Low-penetrance Mutations (Gly2019Ser) and Risk Alleles (Gly2385Arg)—Linking Familial and Sporadic Parkinson’s Disease
2007
Use of Thrombolysis in Acute Ischemic Stroke: Analysis of the Nationwide Inpatient Sample 1999 to 2004
2007
Pyroptosis: mechanisms and diseases
2021 Standout
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
2009 Standout
Role and Therapeutic Potential of VEGF in the Nervous System
2009
Parkinson's disease
2015 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies
2017
A Meta-Analysis of Cytokines in Alzheimer's Disease
2010
Stroke in Young Adults Who Abuse Amphetamines or Cocaine
2007
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Cannabis-Related Stroke: Case Series and Review of Literature
2011
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
2013 Standout
Hypoxia Rescues Frataxin Loss by Restoring Iron Sulfur Cluster Biogenesis
2019 StandoutNobel
Alzheimer's disease
2016 Standout
Cellular Fatty Acid Metabolism and Cancer
2013 Standout
ATP-binding cassette transporter A1: From metabolism to neurodegeneration
2014
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
Cannabis-Related Myocardial Infarction and Cardioembolic Stroke
2010
Interleukin-6, a mental cytokine
2011
The ups and downs of Wnt signaling in prevalent neurological disorders
2006
Genetics of Alzheimer’s Disease
2014
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Vascular endothelial growth factor: a neurovascular target in neurological diseases
2016
Friedreich's Ataxia, No Changes in Mitochondrial Labile Iron in Human Lymphoblasts and Fibroblasts
2004
Review of the Toxicology of Chlorpyrifos With an Emphasis on Human Exposure and Neurodevelopment
2008
Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma
2012
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Catalytic efficiencies of directly evolved phosphotriesterase variants with structurally different organophosphorus compounds in vitro
2015 StandoutNobel
Selective liver X receptor modulators (SLiMs): What use in human health?
2011
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Altered expression of claudin family proteins in Alzheimer's disease and vascular dementia brains
2009
The amyloid hypothesis of Alzheimer's disease at 25 years
2016 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Down Syndrome
2020 Standout
Cannabis Use, Ischemic Stroke, and Multifocal Intracranial Vasoconstriction
2011
Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis
2011
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Neuroimmunological Processes in Parkinson’s Disease and their Relation to α-Synuclein: Microglia as the Referee between Neuronal Processes and Peripheral Immunity
2013
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
2011
Epidemic of illicit drug use, mechanisms of action/addiction and stroke as a health hazard
2011
Novel Approaches to Neuroprotection Trials in Acute Ischemic Stroke
2013
A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and Tuberculosis
2019 StandoutNobel
The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: It's time for reconciliation
2013
Guidelines for the Primary Prevention of Stroke
2014 Standout
Loss‐of‐function mutation in ABCA1 and risk of Alzheimer's disease and cerebrovascular disease
2015
Computational Evolution of Threonine-Rich β-Hairpin Peptides Mimicking Specificity and Affinity of Antibodies
2019 StandoutNobel
A Double-Edged Sword: The Role of VEGF in Wound Repair and Chemoattraction of Opportunist Pathogens
2015
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation
2017 StandoutNobel
Role of Epigenetics in Alzheimer ‘S and Parkinson‘S Disease
2010
The genetic landscape of Alzheimer disease: clinical implications and perspectives
2015
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
1H, 13C and 15N backbone and side chain resonance assignments of human interleukin 1α
2010
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
C10X polymorphism in the CARD8 gene is associated with bacteraemia
2013
Clinical features of Friedreich's ataxia: classical and atypical phenotypes
2013
Racial-Ethnic Disparities in Stroke Care: The American Experience
2011 Standout
Physiology of Microglia
2011 Standout

Works of Ignacio Mateo being referenced

Analysis of the reasons for exclusion from tPA therapy after early arrival in acute stroke patients
2006
Expanded GAA repeats and clinical variation in Friedreich's ataxia
2003
Case-control study of vascular endothelial growth factor (VEGF) genetic variability in Alzheimer's disease
2006
Low serum VEGF levels are associated with Alzheimer's disease
2006
Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer’s disease
2012
LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease
2005
Association between Glycogen Synthase Kinase-3β Genetic Polymorphism and Late-Onset Alzheimer’s Disease
2006
Gene–gene interaction between heme oxygenase-1 and liver X receptor-β and Alzheimer's disease risk
2008
No association between low density lipoprotein receptor genetic variants and Alzheimer's disease risk
2006
Aromatase and interleukin-10 genetic variants interactively modulate Alzheimer’s disease risk
2008
Interaction between CD14 and LXRβ genes modulates Alzheimer's disease risk
2007
Detection of early Alzheimer's disease in MCI patients by the combination of MMSE and an episodic memory test
2011
Inflammation‐related genes and the risk of Parkinson’s disease: a multilocus approach
2008
Friedreich ataxia with minimal GAA expansion presenting as adult-onset spastic ataxia
2002
Serum levels and genetic variation of TGF-β1 are not associated with Alzheimer’s disease
2007
Gene–gene interaction between 14‐3‐3 zeta and butyrylcholinesterase modulates Alzheimer′s disease risk
2008
Recurrent stroke associated with cannabis use
2005
Synergistic Effect of Heme Oxygenase-1 and Tau Genetic Variants on Alzheimer’s Disease Risk
2008
Interaction between Poly(ADP-Ribose) Polymerase 1 and Interleukin 1A Genes Is Associated with Alzheimer’s Disease Risk
2007
DYRK1A genetic variants are not linked to Alzheimer's disease in a Spanish case-control cohort
2009
Deficiency of CARD8 Is Associated with Increased Alzheimer’s Disease Risk in Women
2008
Synergistic effect of two oxidative stress‐related genes (heme oxygenase‐1 and GSK3β) on the risk of Parkinson’s disease
2009
[Cannabis and cerebrovascular disease].
2006
Epistasis Between Intracellular Cholesterol Trafficking-Related Genes (NPC1 and ABCA1) and Alzheimer's Disease Risk
2010
Association of genetic variants of ABCA1 with Alzheimer's disease risk
2007
Serum heme oxygenase-1 levels are increased in Parkinsonâs disease but not in Alzheimerâs disease
2009
Rankless by CCL
2026